Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

IL-22-Activated MUC13 Impacts on Colonic Barrier Function through JAK1/STAT3, SNAI1/ZEB1 and ROCK2/MAPK Signaling.

Autor: Breugelmans T; Laboratory of Experimental Medicine and Pediatrics, Faculty of Medicine and Health Sciences, University of Antwerp, 2610 Antwerp, Belgium.; Infla-Med Research Consortium of Excellence, University of Antwerp, 2610 Antwerp, Belgium., Arras W; Laboratory of Experimental Medicine and Pediatrics, Faculty of Medicine and Health Sciences, University of Antwerp, 2610 Antwerp, Belgium.; Infla-Med Research Consortium of Excellence, University of Antwerp, 2610 Antwerp, Belgium., Oosterlinck B; Laboratory of Experimental Medicine and Pediatrics, Faculty of Medicine and Health Sciences, University of Antwerp, 2610 Antwerp, Belgium.; Infla-Med Research Consortium of Excellence, University of Antwerp, 2610 Antwerp, Belgium., Jauregui-Amezaga A; Laboratory of Experimental Medicine and Pediatrics, Faculty of Medicine and Health Sciences, University of Antwerp, 2610 Antwerp, Belgium.; Department of Gastroenterology and Hepatology, University Hospital of Antwerp, 2650 Antwerp, Belgium., Somers M; Department of Gastroenterology and Hepatology, University Hospital of Antwerp, 2650 Antwerp, Belgium., Cuypers B; Department of Computer Science, Adrem Data Lab, University of Antwerp, 2610 Antwerp, Belgium., Laukens K; Department of Computer Science, Adrem Data Lab, University of Antwerp, 2610 Antwerp, Belgium., De Man JG; Laboratory of Experimental Medicine and Pediatrics, Faculty of Medicine and Health Sciences, University of Antwerp, 2610 Antwerp, Belgium.; Infla-Med Research Consortium of Excellence, University of Antwerp, 2610 Antwerp, Belgium., De Schepper HU; Laboratory of Experimental Medicine and Pediatrics, Faculty of Medicine and Health Sciences, University of Antwerp, 2610 Antwerp, Belgium.; Infla-Med Research Consortium of Excellence, University of Antwerp, 2610 Antwerp, Belgium.; Department of Gastroenterology and Hepatology, University Hospital of Antwerp, 2650 Antwerp, Belgium., De Winter BY; Laboratory of Experimental Medicine and Pediatrics, Faculty of Medicine and Health Sciences, University of Antwerp, 2610 Antwerp, Belgium.; Infla-Med Research Consortium of Excellence, University of Antwerp, 2610 Antwerp, Belgium.; Department of Gastroenterology and Hepatology, University Hospital of Antwerp, 2650 Antwerp, Belgium., Smet A; Laboratory of Experimental Medicine and Pediatrics, Faculty of Medicine and Health Sciences, University of Antwerp, 2610 Antwerp, Belgium.; Infla-Med Research Consortium of Excellence, University of Antwerp, 2610 Antwerp, Belgium.

Publikováno v: Cells [Cells] 2023 Apr 23; Vol. 12 (9). Date of Electronic Publication: 2023 Apr 23.

Epidemiological characteristics of a population visiting a patient-centered informative website about irritable bowel syndrome.

Autor: Van Malderen K; Laboratory of Experimental Medicine and Paediatrics, Faculty of Medicine and Health Sciences, Infla-Med centre of excellence, University of Antwerp, Universiteitsplein 1, Antwerp, Belgium.; Departement of Gastroenterology and hepatology, Antwerp University Hospital, Drie Eikenstraat 655, Edegem, Belgium., De Man JG; Laboratory of Experimental Medicine and Paediatrics, Faculty of Medicine and Health Sciences, Infla-Med centre of excellence, University of Antwerp, Universiteitsplein 1, Antwerp, Belgium., De Winter BY; Laboratory of Experimental Medicine and Paediatrics, Faculty of Medicine and Health Sciences, Infla-Med centre of excellence, University of Antwerp, Universiteitsplein 1, Antwerp, Belgium.; Departement of Gastroenterology and hepatology, Antwerp University Hospital, Drie Eikenstraat 655, Edegem, Belgium., De Schepper HU; Laboratory of Experimental Medicine and Paediatrics, Faculty of Medicine and Health Sciences, Infla-Med centre of excellence, University of Antwerp, Universiteitsplein 1, Antwerp, Belgium.; Departement of Gastroenterology and hepatology, Antwerp University Hospital, Drie Eikenstraat 655, Edegem, Belgium.

Publikováno v: Acta gastro-enterologica Belgica [Acta Gastroenterol Belg] 2023 Jan-Mar; Vol. 86 (1), pp. 17-25.

The Effect of Serine Protease Inhibitors on Visceral Pain in Different Rodent Models With an Intestinal Insult.

Autor: Ceuleers H; Laboratory of Experimental Medicine and Pediatrics, University of Antwerp, Antwerp, Belgium.; Center for Neurogastroenterology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States.; Infla-Med, Centre of Excellence, University of Antwerp, Antwerp, Belgium., Hanning N; Laboratory of Experimental Medicine and Pediatrics, University of Antwerp, Antwerp, Belgium.; Infla-Med, Centre of Excellence, University of Antwerp, Antwerp, Belgium., De Bruyn M; Infla-Med, Centre of Excellence, University of Antwerp, Antwerp, Belgium.; Laboratory of Medical Biochemistry, University of Antwerp, Antwerp, Belgium., De Man JG; Laboratory of Experimental Medicine and Pediatrics, University of Antwerp, Antwerp, Belgium.; Infla-Med, Centre of Excellence, University of Antwerp, Antwerp, Belgium., De Schepper HU; Laboratory of Experimental Medicine and Pediatrics, University of Antwerp, Antwerp, Belgium.; Infla-Med, Centre of Excellence, University of Antwerp, Antwerp, Belgium.; Department of Gastroenterology and Hepatology, Antwerp University Hospital, Antwerp, Belgium., Li Q; Center for Neurogastroenterology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States., Liu L; Center for Neurogastroenterology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States., Abrams S; Global Health Institute, University of Antwerp, Antwerp, Belgium.; Data Science Institute, UHasselt, Hasselt, Belgium., Smet A; Laboratory of Experimental Medicine and Pediatrics, University of Antwerp, Antwerp, Belgium.; Infla-Med, Centre of Excellence, University of Antwerp, Antwerp, Belgium., Joossens J; Laboratory of Medicinal Chemistry, University of Antwerp, Antwerp, Belgium., Augustyns K; Infla-Med, Centre of Excellence, University of Antwerp, Antwerp, Belgium.; Laboratory of Medicinal Chemistry, University of Antwerp, Antwerp, Belgium., De Meester I; Infla-Med, Centre of Excellence, University of Antwerp, Antwerp, Belgium.; Laboratory of Medical Biochemistry, University of Antwerp, Antwerp, Belgium., Pasricha PJ; Center for Neurogastroenterology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States., De Winter BY; Laboratory of Experimental Medicine and Pediatrics, University of Antwerp, Antwerp, Belgium.; Infla-Med, Centre of Excellence, University of Antwerp, Antwerp, Belgium.; Department of Gastroenterology and Hepatology, Antwerp University Hospital, Antwerp, Belgium.

Publikováno v: Frontiers in pharmacology [Front Pharmacol] 2022 Jun 02; Vol. 13, pp. 765744. Date of Electronic Publication: 2022 Jun 02 (Print Publication: 2022).